IL309421A - Deoxynucleoside preparations for the treatment of mitochondrial diseases caused by unbalanced nucleotide pools - Google Patents

Deoxynucleoside preparations for the treatment of mitochondrial diseases caused by unbalanced nucleotide pools

Info

Publication number
IL309421A
IL309421A IL309421A IL30942123A IL309421A IL 309421 A IL309421 A IL 309421A IL 309421 A IL309421 A IL 309421A IL 30942123 A IL30942123 A IL 30942123A IL 309421 A IL309421 A IL 309421A
Authority
IL
Israel
Prior art keywords
optionally substituted
alkyl
prodrug
independently selected
hydrogen
Prior art date
Application number
IL309421A
Other languages
English (en)
Hebrew (he)
Inventor
Daniel Dipietro
Original Assignee
Zogenix Inc
Daniel Dipietro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zogenix Inc, Daniel Dipietro filed Critical Zogenix Inc
Publication of IL309421A publication Critical patent/IL309421A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL309421A 2021-06-18 2022-06-15 Deoxynucleoside preparations for the treatment of mitochondrial diseases caused by unbalanced nucleotide pools IL309421A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163212468P 2021-06-18 2021-06-18
PCT/US2022/033654 WO2022266237A1 (en) 2021-06-18 2022-06-15 Prodrugs of deoxynucleosides for treatment of mitochondrial diseases caused by unbalanced nucleotide pools

Publications (1)

Publication Number Publication Date
IL309421A true IL309421A (en) 2024-02-01

Family

ID=84526701

Family Applications (1)

Application Number Title Priority Date Filing Date
IL309421A IL309421A (en) 2021-06-18 2022-06-15 Deoxynucleoside preparations for the treatment of mitochondrial diseases caused by unbalanced nucleotide pools

Country Status (9)

Country Link
US (2) US20230000890A1 (https=)
EP (1) EP4355336A4 (https=)
JP (1) JP2024522783A (https=)
CN (1) CN117500510A (https=)
AU (1) AU2022291783A1 (https=)
CA (1) CA3222484A1 (https=)
IL (1) IL309421A (https=)
MX (1) MX2023014944A (https=)
WO (1) WO2022266237A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4313068A4 (en) * 2021-03-26 2024-12-25 UCB Biosciences, Inc. Aqueous solutions containing purines and pyrimidines and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10292996B2 (en) * 2015-03-26 2019-05-21 The Trustees Of Columbia University In The City Of New York Deoxyribonucleoside monophospate bypass therapy for mitochondrial DNA depletion syndrome
JP6599484B2 (ja) * 2015-06-17 2019-10-30 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク ミトコンドリアｄｎａ枯渇症候群を含む不均衡なヌクレオチドプールによって引き起こされる疾患のためのデオキシヌクレオシド療法
US10745435B2 (en) * 2015-11-16 2020-08-18 Cerecor, Inc. Nucleic acid prodrugs
US11628182B2 (en) * 2018-04-12 2023-04-18 Zogenix Mds, Inc. Prodrugs of deoxynucleosides for treatment of diseases cased by unbalanced nucleotide pools

Also Published As

Publication number Publication date
AU2022291783A1 (en) 2024-02-01
JP2024522783A (ja) 2024-06-21
US20230000890A1 (en) 2023-01-05
EP4355336A1 (en) 2024-04-24
EP4355336A4 (en) 2025-05-07
US20250049836A1 (en) 2025-02-13
CA3222484A1 (en) 2022-12-22
MX2023014944A (es) 2024-04-25
WO2022266237A1 (en) 2022-12-22
CN117500510A (zh) 2024-02-02

Similar Documents

Publication Publication Date Title
ES2390606T3 (es) Inhibidores de proteasomas
ES2657687T3 (es) Derivados de pirrolopirimidina para uso en el tratamiento de infecciones virales
ES3026734T3 (en) A remdesivir compound for use in treating nipah virus infections
CN106661077B (zh) 4’-硫代核苷的新型化合物及其制备方法、药物组合物和应用
WO2003086408A1 (en) Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases
RU2011127079A (ru) Комбинация производного циклоспорина и нуклеозидов для лечения инфекции вирусом гепатита с
KR20110097754A (ko) 플라빈 유도체
PT1140745E (pt) Derivados de colquinol como agentes de danificacao vascular
DE20121305U1 (de) Nukleosid-Verbindungen
JP2006524710A5 (https=)
AR035711A1 (es) Prodrogas 3' de 2'-desoxi-beta-l-nucleosidos; sus composiciones farmaceuticas; metodo para el tratamiento o profilaxis de una infeccion del virus de la hepatitis b y sus usos para la manufactura de composiciones farmaceuticas
WO2006029081A2 (en) Nucleoside-lipid conjugates, their method of preparation and uses thereof
WO2016020526A1 (en) Indoles for use in influenza virus infection
CN106279321A (zh) 吉西他滨ProTide乏氧活化前药及其应用
RU2009148315A (ru) Составы для перорального введения лекарственных средств и родственные способы
CN112409373A (zh) 作为抗癌剂的取代的[5,6]环-4(3h)-嘧啶酮
IL309421A (en) Deoxynucleoside preparations for the treatment of mitochondrial diseases caused by unbalanced nucleotide pools
RU2007118729A (ru) Пуриновые производные для применения в качестве агонистов аденозинового рецептора а-2а
EP3353159A1 (en) Modified cytotoxins and their therapeutic use
RU2011121354A (ru) Синтетические миметики иммунной защиты и их применение
ES2256845T3 (es) Inmunopotencia de derivados de inosina monofosfato resistentes a 5'-nucleotidasa y utilizacion del mismo.
JP2021521210A5 (https=)
CN101959407A (zh) 4’-硫-2’-去氧核苷作为抗正痘病毒剂的用途
JP5261374B2 (ja) 抗ウイルス性ピリミジンヌクレオシド誘導体
RU2007138582A (ru) Пероральные дозированные формы производных гемцитабина